CN112569171A - Elastin peptide composition and preparation method thereof - Google Patents
Elastin peptide composition and preparation method thereof Download PDFInfo
- Publication number
- CN112569171A CN112569171A CN202110158235.3A CN202110158235A CN112569171A CN 112569171 A CN112569171 A CN 112569171A CN 202110158235 A CN202110158235 A CN 202110158235A CN 112569171 A CN112569171 A CN 112569171A
- Authority
- CN
- China
- Prior art keywords
- composition
- preparation
- group
- components
- glycerol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Cosmetics (AREA)
Abstract
The invention belongs to the technical field of cosmetics, and discloses components of elastin peptide and a preparation method thereof, wherein the components of a group preparation comprise water and panthenol, the components of a group preparation B comprise water and sodium hyaluronate, the components of a group preparation C comprise a polymethylsilsesquioxane composition, the components of a group preparation D comprise a polyacrylamide composition, the components of a group preparation E comprise lemon yellow and amaranth, the components of a group preparation F comprise 1, 2-pentanediol, an octylglycol composition, essence and chamomile oil, the components of a group preparation G comprise a glycerin composition, a beta-glucan composition, a lily extract composition, a 1, 2-hexanediol composition, a glycerin composition, a hexyldecanol composition, a hydrolyzed collagen composition and a butanediol composition, the components of a group preparation H comprise butanediol and polyethylene glycol, and keratin is matched with elastin peptide in a beating and drawing process, promoting active components to penetrate into cells and be absorbed, strongly stimulating collagen, improving antiaging effect, and reducing fine lines.
Description
Technical Field
The invention belongs to the technical field of cosmetics, and particularly relates to an elastin peptide component and a preparation method thereof.
Background
Elastin is a structurally large, highly cross-linked, complex, hydrophobic, water-insoluble protein that, as a major extracellular matrix protein, constitutes the "core" of the elastic fiber. Elastin has now been found in two forms: elastin I is present in ligaments, aorta and skin, and elastin II is available from cartilage. Elastin is an important component of skin composition, contains only 5% of skin, and is a key for stimulating the generation of skin collagen and elastic fibers, wherein the collagen determines the softness and fullness of the skin, and the elastic fibers determine the tightness and elasticity of the skin.
Elastin-derived peptides (EDPs) are degradation products of elastin. Degradation of elastin includes both biological enzymatic degradation, commonly referred to as elastin solubilization, and chemical degradation, referred to as elastin peptide synthesis. Elastin peptide generates chemotaxis to fibroblast and monocyte, so that the adhesion of elastic fiber and fibroblast is enhanced, elastin peptide can stimulate the activity enhancement of Neu-1 sialidase, the activity enhancement of Neu-1 can cause the release of soluble elastin, and the elastin aggregates into clusters or interacts with microfiber components to form elastic fiber, thereby improving the elasticity of skin and being very effective for preventing and improving wrinkle or relaxation.
Disclosure of Invention
In order to solve the above problems of the prior art, the present invention aims to provide a composition of elastin peptide and a preparation method thereof.
The technical scheme adopted by the invention is as follows: the elastin peptide component comprises A, B, C, D, E, F, G, H group preparations, wherein the A group preparations comprise water and panthenol, the B group preparations comprise water and sodium hyaluronate, the C group preparations comprise polymethylsilsesquioxane compositions, the D group preparations comprise polyacrylamide compositions, the E group preparations comprise lemon yellow and amaranth, the F group preparations comprise 1, 2-pentanediol, caprylyl glycol compositions, essences and chamomile oil, the G group preparations comprise glycerol compositions, beta-glucan compositions, lily extract compositions, 1, 2-hexanediol compositions, glycerol compositions, hexyldecanol compositions, hydrolyzed collagen compositions and butanediol compositions, and the H group preparations comprise butanediol, butylene glycol, panthenol and sodium hyaluronate, Polyethylene glycol, the preparation method of the preparation comprises the following steps:
firstly, uniformly dispersing a preparation in a group H for later use;
secondly, adding the preparation A and the preparation B into an emulsifying pot, stirring and heating to 90 ℃, keeping the temperature for 10 min, cooling to 80 ℃, adding the preparation C and the preparation D, and homogenizing for 3 min; step three: cooling to 75 ℃, and defoaming at constant temperature; step four: cooling to 45 deg.C, adding raw materials of group E preparation, group F preparation, and group G preparation, homogenizing for 1 min, and stirring; adding the preparation in the group H, and uniformly stirring the mixture: cooling to 38 deg.C, filtering with 200 mesh filter cloth, and discharging.
Further, the components of the preparation group A comprise water (80.774%) and panthenol (0.2%) in percentage proportion, the components of the preparation group B comprise water (3%) and sodium hyaluronate (0.03%), the components of the preparation group C comprise polymethylsilsesquioxane composition (5%), the components of the preparation group D comprise polyacrylamide composition (2.5%), the components of the preparation group E comprise lemon yellow (0.0001%) and amaranth (0.00002%), the components of the preparation group F comprise 1, 2-pentanediol (3%), caprylyl glycol composition (0.4%), essence (0.02%), and chamomile oil (0.01%), and the components of the preparation group G comprise glycerin composition (0.01%), beta-glucan composition (0.3%), lily extract composition (0.5%), 1, 2-hexanediol composition (0.01%), and a mixture of water, panthenol and panthenol (0.2%), wherein the components of the preparation group B comprise citric acid, amaranth (0.0001%), amaranth (0.00002%), and the components of the, Glycerol composition (0.001%), hexyldecanol composition (0.001%), hydrolyzed collagen composition (0.001%), butylene glycol composition (0.001%), the ingredients of said group H formulation comprising butylene glycol (4%), polyethylene glycol (0.23%).
Still further, the polymethylsilsesquioxane composition (5%) included polymethylsilsesquioxane (40%), dimethicone (32%), isohexadecane (15%), PEG-40 stearate (5%), cetearyl methicone (3%), steareth-2 (3%), steareth-21 (2%).
Furthermore, the polyacrylamide composition (2.5%) comprises polyacrylamide (35%), C13-14 isoparaffin (15%), laureth-7 (5%), and water (45%).
Furthermore, the proportion of the caprylyl glycol composition (0.4%) comprises caprylyl glycol (50%), 1, 2-hexanediol (50%).
Further, the glycerol composition (0.01%) comprises water (49%), glycerol (50%), dipeptide diaminobutyrylbenzylamide diacetate (1%); the proportion of the beta-glucan composition (0.3%) included water (82%), glycerol (5%), beta-glucan (1%), 1, 2-hexanediol (1%), caprylyl glycol (0.06%), sodium benzoate (0.4%).
Furthermore, the lily extract composition (0.5%) comprises the lilium nipponicum extract (20%), tremella polysaccharide (25%), beta-glucan (29.9%), butanediol (25%), ethylhexyl glycerol (0.03%), caprylyl hydroxamic acid (0.04%), and 1, 2-hexanediol (0.03%).
Further, the 1, 2-hexanediol composition (0.01%) included water (80%), 1, 2-hexanediol (15%), capryl hydroxamic acid (1%), ethylhexyl glycerin (1%), palmitoyl tetrapeptide-7 (0.5%), acetyl hexapeptide-8 (0.5%), palmitoyl pentapeptide-4 (0.5%), polyacrylic acid (0.01%), polysorbate-20 (0.01%), butylene glycol (0.48%), and propylene glycol (1%).
Furthermore, the glycerol composition (0.001%) includes water (50%), glycerol (46%), wild soybean protein (1%), superoxide dismutase (SOD) (1%), dextran sulfate sodium (1%), phenoxyethanol (0.7%), ethylhexyl glycerol (0.1%), sodium benzoate (0.1%), potassium sorbate (0.1%), and the hexyldecanol composition (0.001%) includes hexyldecanol (84%), bisabolol (5%), cetylhydroxyproline cetylwax ester (5%), stearic acid (5%), campesterol (1%).
Furthermore, the hydrolyzed collagen composition (0.001%) comprises water (40%), hydrolyzed collagen (56%), butylene glycol (4%), and the butylene glycol composition (0.001%) comprises water (55%), butylene glycol (10%), propylene glycol (10%), tea extract (10%), lecithin (5%), feverfew extract (5%), and magnolol (5%).
The invention has the beneficial effects that:
1. the keratin is converted into 20 amino acids such as serine, methionine, cysteine and the like in the beating and wire drawing process by matching with elastin peptide; the keratin is compounded with amino acid, so that the viscosity of the product is controlled to be similar to that of intercellular lipid, and the active ingredients are promoted to permeate into cells and be absorbed more quickly.
2. The ceramide compound with a structure similar to natural ceramide is adopted, intercellular lipid is quickly and densely supplemented, and efficient repair is realized; the hydrolyzed collagen can additionally release small molecular polypeptides in the beating and wire drawing processes, and the small molecular polypeptides are matched with the existing peptides in the formula, and jointly act on the muscle base to strongly stimulate the collagen, improve the anti-aging effect and reduce fine lines and deep lines; the microcapsule coating technology can protect active ingredients, and has the effect of optimal absorption rate of the active ingredients with minimum concentration.
Detailed Description
The present invention is further illustrated below with reference to specific examples.
Example (b):
the embodiment provides ingredients of elastin peptide and a preparation method thereof, comprising A, B, C, D, E, F, G, H groups of preparations, wherein the ingredients of the A group of preparations comprise water and panthenol, the ingredients of the B group of preparations comprise water and sodium hyaluronate, the ingredients of the C group of preparations comprise polymethylsilsesquioxane compositions, the ingredients of the D group of preparations comprise polyacrylamide compositions, the ingredients of the E group of preparations comprise lemon yellow and amaranth, the ingredients of the F group of preparations comprise 1, 2-pentanediol, caprylyl glycol compositions, essence and chamomile oil, the ingredients of the G group of preparations comprise glycerin compositions, beta-glucan compositions, lily extract compositions, 1, 2-hexanediol compositions, glycerin compositions, hexyldecanol compositions, hydrolyzed collagen compositions and butanediol compositions, the component of the H group preparation comprises butanediol and polyethylene glycol, and the preparation method of the preparation comprises the following steps:
firstly, uniformly dispersing a preparation in a group H for later use;
secondly, adding the preparation A and the preparation B into an emulsifying pot, stirring and heating to 90 ℃, keeping the temperature for 10 min, cooling to 80 ℃, adding the preparation C and the preparation D, and homogenizing for 3 min; step three: cooling to 75 ℃, and defoaming at constant temperature; step four: cooling to 45 deg.C, adding raw materials of group E preparation, group F preparation, and group G preparation, homogenizing for 1 min, and stirring; adding the preparation in the group H, and uniformly stirring the mixture: cooling to 38 deg.C, filtering with 200 mesh filter cloth, and discharging.
Specifically, the components of the preparation group A comprise water (80.774%) and panthenol (0.2%) in percentage ratio, the components of the preparation group B comprise water (3%) and sodium hyaluronate (0.03%), the components of the preparation group C comprise polymethylsilsesquioxane composition (5%), the components of the preparation group D comprise polyacrylamide composition (2.5%), the components of the preparation group E comprise lemon yellow (0.0001%) and amaranth (0.00002%), the components of the preparation group F comprise 1, 2-pentanediol (3%), caprylyl glycol composition (0.4%), essence (0.02%), and chamomile oil (0.01%), and the components of the preparation group G comprise glycerin composition (0.01%), beta-glucan composition (0.3%), lily extract composition (0.5%), 1, 2-hexanediol composition (0.01%), and the mixture of the mixture group C comprises glycerol composition (0.01%), beta-glucan composition (0.3%), lily extract composition (0.5%), and a mixture of 1, 2-hexanediol (0.01%) Glycerol composition (0.001%), hexyldecanol composition (0.001%), hydrolyzed collagen composition (0.001%), butylene glycol composition (0.001%), the ingredients of said group H formulation comprising butylene glycol (4%), polyethylene glycol (0.23%).
Specifically, the polymethyl silsesquioxane composition (5%) comprises polymethyl silsesquioxane (40%), polydimethylsiloxane (32%), isohexadecane (15%), PEG-40 stearate (5%), cetearyl polymethylsiloxane (3%), steareth-2 (3%), steareth-21 (2%), the polyacrylamide composition (2.5%) comprises polyacrylamide (35%), C13-14 isoparaffin (15%), laureth-7 (5%), water (45%), the caprylyl glycol composition (0.4%) comprises caprylyl glycol (50%), 1, 2-hexanediol (50%), and the glycerin composition (0.01%) comprises water (49%), glycerin (50%), and, Dipeptide diaminobutyrylbenzylamide diacetate (1%); beta-glucan composition (0.3%) including water (82%), glycerol (5%), beta-glucan (1%), 1, 2-hexanediol (1%), caprylyl glycol (0.06%), sodium benzoate (0.4%), lily extract composition (0.5%) including lily japanese extract (20%), tremella polysaccharide (25%), beta-glucan (29.9%), butanediol (25%), ethylhexyl glycerol (0.03%), caprylyl hydroxamic acid (0.04%), 1, 2-hexanediol (0.03%), 1, 2-hexanediol composition (0.01%) including water (80%), 1, 2-hexanediol (15%), caprylyl hydroxamic acid (1%), ethylhexyl glycerol (1%), palmitoyl tetrapeptide-7 (0.5%), acetyl hexapeptide-8 (0.5%), (0.5%), Palmitoyl pentapeptide-4 (0.5%), polyacrylic acid (0.01%), polysorbate-20 (0.01%), butylene glycol (0.48%), propylene glycol (1%), and the glycerol composition (0.001%) includes water (50%), glycerol (46%), wild soybean protein (1%), superoxide dismutase (SOD) (1%), dextran sulfate sodium (1%), phenoxyethanol (0.7%), ethylhexyl glycerol (0.1%), sodium benzoate (0.1%), potassium sorbate (0.1%), and the hexyldecanol composition (0.001%) includes hexyldecanol (84%), bisabolol (5%), cetyl N-palmitoyl hydroxyproline (5%), stearic acid (5%), brassinols (1%), and the hydrolyzed collagen composition (0.001%) includes water (40%, hydrolyzed collagen (56%), butylene glycol (4%), and the butylene glycol composition (0.001%) included water (55%), butylene glycol (10%), propylene glycol (10%), tea extract (10%), lecithin (5%), feverfew extract (5%), and magnolol (5%).
The present invention is not limited to the above-described alternative embodiments, and various other forms of products can be obtained by anyone in light of the present invention. The above detailed description should not be taken as limiting the scope of the invention, which is defined in the claims, and which the description is intended to be interpreted accordingly.
Claims (10)
1. The elastin peptide component and its preparation method, characterized by that: comprising A, B, C, D, E, F, G, H groups of preparations, wherein the components of the A group of preparations comprise water and panthenol, the components of the preparation B comprise water and sodium hyaluronate, the components of the preparation C comprise polymethylsilsesquioxane composition, the components of the D group preparation comprise a polyacrylamide composition, the components of the E group preparation comprise lemon yellow and amaranth, the component of the F group preparation comprises 1, 2-pentanediol, an octylene glycol composition, essence and chamomile oil, the group G preparation comprises glycerol composition, beta-glucan composition, Bulbus Lilii extract composition, 1, 2-hexanediol composition, glycerol composition, hexyldecanol composition, hydrolyzed collagen composition, and butanediol composition, the component of the H group preparation comprises butanediol and polyethylene glycol, and the preparation method of the preparation comprises the following steps:
firstly, uniformly dispersing a preparation in a group H for later use;
secondly, adding the preparation A and the preparation B into an emulsifying pot, stirring and heating to 90 ℃, keeping the temperature for 10 min, cooling to 80 ℃, adding the preparation C and the preparation D, and homogenizing for 3 min; step three: cooling to 75 ℃, and defoaming at constant temperature; step four: cooling to 45 deg.C, adding raw materials of group E preparation, group F preparation, and group G preparation, homogenizing for 1 min, and stirring; adding the preparation in the group H, and uniformly stirring the mixture: cooling to 38 deg.C, filtering with 200 mesh filter cloth, and discharging.
2. The elastin peptide component of claim 1 and method of making the same, comprising: the percentage ratio of the components of the preparation group A comprises water (80.774%), panthenol (0.2%), the components of the preparation group B comprises water (3%), sodium hyaluronate (0.03%), the components of the preparation group C comprises a polymethylsilsesquioxane composition (5%), the components of the preparation group D comprises a polyacrylamide composition (2.5%), the components of the preparation group E comprises lemon yellow (0.0001%), amaranth (0.00002%), the components of the preparation group F comprises 1, 2-pentanediol (3%), an octylglycol composition (0.4%), essence (0.02%), and chamomile oil (0.01%), and the components of the preparation group G comprise a glycerin composition (0.01%), a beta-glucan composition (0.3%), a lily extract composition (0.5%), a 1, 2-hexanediol composition (0.01%) Glycerol composition (0.001%), hexyldecanol composition (0.001%), hydrolyzed collagen composition (0.001%), butylene glycol composition (0.001%), the ingredients of said group H formulation comprising butylene glycol (4%), polyethylene glycol (0.23%).
3. The elastin peptide component of claim 2 and method of making the same, comprising: the polymethylsilsesquioxane composition (5%) comprises polymethylsilsesquioxane (40%), polydimethylsiloxane (32%), isohexadecane (15%), PEG-40 stearate (5%), cetearyl polymethylsiloxane (3%), steareth-2 (3%), and steareth-21 (2%).
4. The elastin peptide component of claim 2 and method of making the same, comprising: the polyacrylamide composition (2.5%) comprises polyacrylamide (35%), C13-14 isoparaffin (15%), laureth-7 (5%) and water (45%).
5. The elastin peptide component of claim 2 and method of making the same, comprising: the proportion of the caprylyl glycol composition (0.4%) comprises caprylyl glycol (50%) and 1, 2-hexanediol (50%).
6. The elastin peptide component of claim 2 and method of making the same, comprising: the glycerol composition (0.01%) comprises water (49%), glycerol (50%), dipeptide diaminobutyrylbenzylamide diacetate (1%); the proportion of the beta-glucan composition (0.3%) included water (82%), glycerol (5%), beta-glucan (1%), 1, 2-hexanediol (1%), caprylyl glycol (0.06%), sodium benzoate (0.4%).
7. The elastin peptide component of claim 2 and method of making the same, comprising: the lily extract composition (0.5%) comprises a lilium japonicum extract (20%), tremella polysaccharide (25%), beta-glucan (29.9%), butanediol (25%), ethylhexyl glycerol (0.03%), caprylyl hydroxamic acid (0.04%) and 1, 2-hexanediol (0.03%).
8. The elastin peptide component of claim 2 and method of making the same, comprising: the proportion of the 1, 2-hexanediol composition (0.01%) comprises water (80%), 1, 2-hexanediol (15%), caprylyl hydroxamic acid (1%), ethylhexyl glycerol (1%), palmitoyl tetrapeptide-7 (0.5%), acetyl hexapeptide-8 (0.5%), palmitoyl pentapeptide-4 (0.5%), polyacrylic acid (0.01%), polysorbate-20 (0.01%), butanediol (0.48%) and propylene glycol (1%).
9. The elastin peptide component of claim 2 and method of making the same, comprising: the glycerol composition (0.001%) comprises water (50%), glycerol (46%), wild soybean protein (1%), superoxide dismutase (SOD) (1%), dextran sulfate sodium (1%), phenoxyethanol (0.7%), ethylhexyl glycerol (0.1%), sodium benzoate (0.1%), potassium sorbate (0.1%), and the hexyldecanol composition (0.001%) comprises hexyldecanol (84%), bisabolol (5%), N-palmitoyl hydroxyproline cetyl ester (5%), stearic acid (5%) and brassinols (1%).
10. The elastin peptide component of claim 2 and method of making the same, comprising: the hydrolyzed collagen composition (0.001%) comprises water (40%), hydrolyzed collagen (56%) and butanediol (4%), and the butanediol composition (0.001%) comprises water (55%), butanediol (10%), propylene glycol (10%), tea extract (10%), lecithin (5%), feverfew extract (5%) and magnolol (5%).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110158235.3A CN112569171A (en) | 2021-02-05 | 2021-02-05 | Elastin peptide composition and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110158235.3A CN112569171A (en) | 2021-02-05 | 2021-02-05 | Elastin peptide composition and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112569171A true CN112569171A (en) | 2021-03-30 |
Family
ID=75145491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110158235.3A Pending CN112569171A (en) | 2021-02-05 | 2021-02-05 | Elastin peptide composition and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112569171A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112972339A (en) * | 2021-04-12 | 2021-06-18 | 东晟源研究院(广州)有限公司 | Blue light prevention spray |
| CN113057914A (en) * | 2021-04-12 | 2021-07-02 | 东晟源研究院(广州)有限公司 | Moisturizing and soothing spray |
| CN114272174A (en) * | 2021-12-28 | 2022-04-05 | 赵彬 | Elastin peptide composition and preparation method thereof |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106265130A (en) * | 2016-09-29 | 2017-01-04 | 防城港市港口区高创信息技术有限公司 | A kind of compositions for skin repair and preparation method thereof |
| CN106265338A (en) * | 2016-09-14 | 2017-01-04 | 广东丸美生物技术股份有限公司 | A kind of skin care oil and preparation method that there is Whitening, spot and purify smooth skin |
| CN106726668A (en) * | 2016-11-19 | 2017-05-31 | 诺斯贝尔化妆品股份有限公司 | A kind of many peptidoliposome raw materials used in cosmetics |
| CN107519049A (en) * | 2017-09-07 | 2017-12-29 | 蝶柔化妆品(浙江)有限公司 | A kind of body frost of healthy skin |
| CN108904408A (en) * | 2018-08-16 | 2018-11-30 | 余荣华 | A kind of formula of anti-wrinkle product |
| CN109330955A (en) * | 2018-10-31 | 2019-02-15 | 济南康民药业科技有限公司 | A kind of oriental cherry facial mask |
| CN109568236A (en) * | 2019-02-12 | 2019-04-05 | 广州思薇伦特美容生物科技有限公司 | A kind of sponge micropin reconciles Essence and preparation method thereof |
| CN110236991A (en) * | 2019-07-28 | 2019-09-17 | 苏州三点三生物科技有限公司 | A kind of Moringa facial mask |
-
2021
- 2021-02-05 CN CN202110158235.3A patent/CN112569171A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106265338A (en) * | 2016-09-14 | 2017-01-04 | 广东丸美生物技术股份有限公司 | A kind of skin care oil and preparation method that there is Whitening, spot and purify smooth skin |
| CN106265130A (en) * | 2016-09-29 | 2017-01-04 | 防城港市港口区高创信息技术有限公司 | A kind of compositions for skin repair and preparation method thereof |
| CN106726668A (en) * | 2016-11-19 | 2017-05-31 | 诺斯贝尔化妆品股份有限公司 | A kind of many peptidoliposome raw materials used in cosmetics |
| CN107519049A (en) * | 2017-09-07 | 2017-12-29 | 蝶柔化妆品(浙江)有限公司 | A kind of body frost of healthy skin |
| CN108904408A (en) * | 2018-08-16 | 2018-11-30 | 余荣华 | A kind of formula of anti-wrinkle product |
| CN109330955A (en) * | 2018-10-31 | 2019-02-15 | 济南康民药业科技有限公司 | A kind of oriental cherry facial mask |
| CN109568236A (en) * | 2019-02-12 | 2019-04-05 | 广州思薇伦特美容生物科技有限公司 | A kind of sponge micropin reconciles Essence and preparation method thereof |
| CN110236991A (en) * | 2019-07-28 | 2019-09-17 | 苏州三点三生物科技有限公司 | A kind of Moringa facial mask |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112972339A (en) * | 2021-04-12 | 2021-06-18 | 东晟源研究院(广州)有限公司 | Blue light prevention spray |
| CN113057914A (en) * | 2021-04-12 | 2021-07-02 | 东晟源研究院(广州)有限公司 | Moisturizing and soothing spray |
| CN114272174A (en) * | 2021-12-28 | 2022-04-05 | 赵彬 | Elastin peptide composition and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112569171A (en) | Elastin peptide composition and preparation method thereof | |
| JP5296984B2 (en) | Cosmetic or dermatological composition for inhibiting skin aging phenomenon | |
| CA2818723C (en) | Exopolysaccharide produced by pseudoaltermonas sp. useful for the treatment and care of the skin, mucous membranes, hair and/or nails | |
| US20200345599A1 (en) | Composition For Surface Modification | |
| CN103505403B (en) | Epidermal growth factor composite liposome body and its preparation method and application | |
| CN104173251B (en) | A kind of bone glue of yak former peptide cleawhite pack and preparation method thereof | |
| JP2005501805A5 (en) | ||
| JP2008526954A (en) | Cosmetic or dermatological pharmaceutical composition containing Euglena extract | |
| WO2009034537A2 (en) | Cosmetic composition comprising hydroxymethionine and 3-aminopropanesulfonic acid | |
| JP2010070492A (en) | Cosmetic product | |
| JP2015510919A (en) | Exopolysaccharides for the treatment and / or care of skin, mucous membranes and / or nails | |
| CN109833221A (en) | A kind of anti-ageing aging facial treatment milk of eye and preparation method thereof | |
| KR20190010795A (en) | Moisturizing, anti-wrinkling, and whitening cosmetic composition comprising novel Hyalpol Matrix Mixture and preparation method of the same | |
| JP5726481B2 (en) | Cosmetic or skin external preparation containing hydroxynicotinic acid or a derivative thereof | |
| CN116847871A (en) | Skin care compositions and methods of use | |
| JP2016094358A (en) | Cellulose nanofiber dispersoid and cosmetic composition using the same | |
| CN108635273A (en) | A kind of sun-proof sun screen of wrinkle resistance, whitening and preparation method thereof | |
| CN115023271B (en) | Hair improvement method | |
| CN114652628A (en) | Anti-aging cream for beautifying chest and body and enhancing skin immune barrier and preparation method thereof | |
| JP2019099530A (en) | Hyaluronic acid production promoter | |
| CN114557909A (en) | Multiple peptide anti-wrinkle essence and preparation method thereof | |
| JP2018145106A (en) | Skin external compositions | |
| CN113143790A (en) | Hair care nutritional composition, leave-on hair care product, and preparation method and application thereof | |
| CN113662876A (en) | Polypeptide beautifying essence and preparation method thereof | |
| US9040097B2 (en) | Compositions for improving skin appearance |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210330 |